Bio-Techne Corporation
TECH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $287 | $317 | $316 | $297 |
| % Growth | -9.6% | 0.2% | 6.4% | – |
| Cost of Goods Sold | $96 | $118 | $102 | $103 |
| Gross Profit | $190 | $199 | $215 | $194 |
| % Margin | 66.4% | 62.7% | 67.9% | 65.3% |
| R&D Expenses | $24 | $26 | $25 | $25 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $115 | $23 | $151 | $121 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $173 | $0 | $0 |
| Operating Expenses | $139 | $223 | $176 | $146 |
| Operating Income | $51 | -$24 | $39 | $47 |
| % Margin | 17.7% | -7.5% | 12.2% | 16% |
| Other Income/Exp. Net | -$3 | $1 | -$0 | -$5 |
| Pre-Tax Income | $48 | -$23 | $38 | $43 |
| Tax Expense | $10 | -$5 | $16 | $8 |
| Net Income | $38 | -$18 | $23 | $35 |
| % Margin | 13.3% | -5.6% | 7.1% | 11.7% |
| EPS | 0.25 | -0.11 | 0.14 | 0.22 |
| % Growth | 327.3% | -178.6% | -36.4% | – |
| EPS Diluted | 0.24 | -0.11 | 0.14 | 0.22 |
| Weighted Avg Shares Out | 155 | 155 | 157 | 158 |
| Weighted Avg Shares Out Dil | 156 | 155 | 159 | 161 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $1 |
| Interest Expense | $5 | $2 | $2 | $2 |
| Depreciation & Amortization | $24 | $27 | $28 | $27 |
| EBITDA | $78 | $6 | $68 | $72 |
| % Margin | 27.1% | 2% | 21.5% | 24.3% |